Back

PRIME Education, Inc. (PRIME®)

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors

Transforming LDL-C Management: Advancing Treatment Beyond Statins to Reduce ASCVD Risk

Tune in to this recording from a live satellite symposium at the American Academy of Family Physicians’ (AAFP) 2025 Family Medicine Experience to gain practical strategies for using nonstatin therapies to optimize LDL-C management across the ASCVD risk spectrum. Learn from leading experts as they break down current guideline recommendations, examine the latest clinical evidence, and work through patient cases commonly encountered in daily practice. Discussions focus on how to individualize LDL-C goals, know when and how to escalate treatment, and confidently reduce cardiovascular risk through personalized, evidence-based treatment plans.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case study / clinical scenario
  • includes On-demand / recorded video
  • Credit · Up to 1.5 credits
  • Commercial Support
  • Released
    Oct 31, 2025
  • Last day to claim credit
    Oct 31, 2026 3 weeks left